Hepatic and metabolic effects of SGLT2 inhibitors in type 2 diabetes and MASLD assessed by metabolomic and lipidomic analysis
K
Kenan Moral
E
Engin Koçak
S
Sevilay Erdoğan Kablan
E
Emirhan Nemutlu
H
Halit Nahit Şendur
M
Mahinur Cerit
M
Mehmet Muhittin Yalçın
G
Gulden Bilican
M
Mehmet Cindoruk
T
Tarkan Karakan
K
Kübra Vardar
N
Nergiz Ekmen
Article Details
Journal
Scientific Reports
Volume / Issue
Vol. 16, Issue 1
Published
May 02, 2026
ISSN
2045-2322
Publisher
Nature Portfolio
Authors (12)
K
Kenan Moral
E
Engin Koçak
S
Sevilay Erdoğan Kablan
E
Emirhan Nemutlu
H
Halit Nahit Şendur
M
Mahinur Cerit
M
Mehmet Muhittin Yalçın
G
Gulden Bilican
M
Mehmet Cindoruk
T
Tarkan Karakan
K
Kübra Vardar
N
Nergiz Ekmen
Related Articles from this Journal
AI models of unstable flow exhibit hallucination
Ramdhan Wibawa, Birendra Jha
Aug 2026
10.1038/s41598-026-64023-8
The MCAA-YOLO + XPBI integrated model provides a hybrid intelligent measurement method for predicting the body weight of Hu sheep
Hang Zhang, Yuang Cheng et al.
Aug 2026
10.1038/s41598-026-64075-w
Application of iron nano-biofertilizers as a sustainable approach to enhance growth and micronutrient uptake in soybean
Ava Mohrazi, Reza Ghasemi-Fasaei
Aug 2026
10.1038/s41598-026-66011-4
Adolescents’ status-dependent public and private conformity to prosocial and antisocial decisions in a public goods game
Niloofar Saeedi, Khatereh Borhani et al.
Aug 2026
10.1038/s41598-026-64831-y
An explainable hierarchical capsule network framework for supporting expert sensory evaluation of herbal medicines with natural language generation
Hyein Lee, Dae-Hyun Jung
Aug 2026
10.1038/s41598-026-64156-w